Skip to : [Content] [Navigation]
 

Originally Published MDDI October 2004

NEWSTRENDS

FDA Allows OTC Defibrillators
The HeartStart Home Defibrillator is now available without a prescription.

Erik Swain


In a significant move keeping with today’s trend of giving the patient more control over his or her treatment, on September 16, FDA approved over-the-counter sales for an automatic external defibrillator (AED).

Consumers will now be able to buy the HeartStart Home Defibrillator, made by Philips Medical Systems (Andover, MA), without a prescription. In 2002, the HeartStart became the first external defibrillator designed specifically for home use to gain FDA approval.

AEDs administer an electric shock through the chest wall to the heart, using conductive adhesive pads. They have computers to analyze heart rhythm and alert the user when a shock is needed.

Philips was able to prove to FDA that its AED could be used without medical supervision. It demonstrated that the device and its instructions could be safely and effectively used and understood by lay people. Tests studied the ability of untrained users to set up the device, place the pads in their proper place, follow voice and visual prompts, and safely deliver shocks. The company also wrote a new set of instructions and training manuals.

“It is important to recognize that for a substantial percentage of [sudden cardiac arrest] victims, cardiac arrest is the first sign of heart disease,” said Jeremy Ruskin, director of the cardiac arrhythmia service at Massachusetts General Hospital (Boston). “We know that access to early defibrillation helps save lives. Removal of the prescription requirement for the HeartStart Home Defibrillator gives people freedom of choice to be better prepared for unexpected cardiac arrest—a rare but life-threatening emergency.”

The OTC approval came after a recommendation by the agency’s Circulatory Systems Panel in July. At that meeting, physicians, industry representatives, and sudden cardiac arrest survivors came to a consensus that greater access to defibrillators should save lives.

Copyright ©2004 Medical Device & Diagnostic Industry